Ilaraz 20 Tablet contains Ilaprazole 20mg, a proton pump inhibitor (PPI) used primarily for the treatment of acid-related gastrointestinal conditions. Ilaprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This action provides effective relief from symptoms associated with gastroesophageal reflux disease (GERD), peptic ulcer disease, Zollinger-Ellison syndrome, and erosive esophagitis. Ilaraz 20 is indicated for healing and maintenance therapy of erosive esophagitis, management of duodenal and gastric ulcers, and prevention of NSAID-induced gastropathy. The tablet is typically administered orally once daily, preferably before meals, with dosage adjustments based on clinical response and severity of the condition. Ilaprazole has a favorable pharmacokinetic profile, with rapid absorption and a prolonged duration of acid suppression. Common adverse effects may include headache, abdominal pain, nausea, and diarrhea, though it is generally well tolerated. Caution is advised in patients with hepatic impairment, and it should be used under medical supervision to avoid potential drug interactions, particularly with medications requiring gastric pH for absorption. Ilaraz 20 Tablet offers an effective therapeutic option for managing acid-related disorders and improving patient quality of life.